Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.

Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD.

J Natl Cancer Inst. 2008 Oct 15;100(20):1432-8. doi: 10.1093/jnci/djn326. Epub 2008 Oct 7.

2.

Combining information from common type 2 diabetes risk polymorphisms improves disease prediction.

Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, Zeggini E, Rayner NW, Shields B, Owen KR, Hattersley AT, Frayling TM.

PLoS Med. 2006 Oct;3(10):e374.

3.

Medical genetics in the genomic medicine of the 21st century.

Epstein CJ.

Am J Hum Genet. 2006 Sep;79(3):434-8. No abstract available.

4.
5.
6.

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P.

Am J Epidemiol. 2004 May 1;159(9):882-90. Review.

PMID:
15105181
7.

Combining several screening tests: optimality of the risk score.

McIntosh MW, Pepe MS.

Biometrics. 2002 Sep;58(3):657-64.

PMID:
12230001
8.

Gene expression profiling predicts clinical outcome of breast cancer.

van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH.

Nature. 2002 Jan 31;415(6871):530-6.

PMID:
11823860
9.

Supplemental Content

Support Center